BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 4,550.00
0.00 (0.00%)
At close: Feb 19, 2026
BioInfra Company Description
BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.
The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing.
It also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs; and sample analysis services for new drug substances.
The company was founded in 2007 and is based in Yongin-si, South Korea.
BioInfra Co., Ltd.
| Country | South Korea |
| Founded | 2007 |
| Industry | Commercial Physical and Biological Research |
Contact Details
Address: 120 Heungdeokjungang-ro Yongin-si South Korea | |
| Phone | 82 3 1627 2800 |
| Website | bioinfrakorea.co.kr |
Stock Details
| Ticker Symbol | 199730 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Sangdeuk Lee | Chief Executive Officer |